Amarin Corp plcAMRNEarnings & Financial Report
Nasdaq · Health Care · Pharmaceutical Preparations
Amarin Corporation is an Irish-American biopharmaceutical company founded in 1993 and headquartered in Dublin, Ireland and Bridgewater, New Jersey. The company develops and markets medicines for the treatment of cardiovascular disease. It has developed the drug Vascepa (AMR-101), a prescription grade omega-3 fatty acid.
Top Holders
| Holder | % Owned | Shares | Change | As of |
|---|---|---|---|---|
| Sarissa Capital Management LP | 8.20% | 33.5M | ▲ +1.02pp | 2023-12-05 |
Insider Transactions
Net 90d: +$0 · buys $0 / sells $0Range:
Action:
Role:
| Insider | Role | Action | ||||
|---|---|---|---|---|---|---|
| 2026-04-18 | Bonfiglio Patrice Eadon | Director | Option exercise | 838 | — | — |
| 2026-04-18 | O'Connor Oliver | Director | Option exercise | 838 | — | — |
| 2026-04-18 | Sullivan Diane E. | Director | Option exercise | 838 | — | — |
| 2026-04-18 | Sterling Louis III | Director | Option exercise | 838 | — | — |
| 2026-04-18 | Paul Cohen | Director | Option exercise | 838 | — | — |
| 2026-04-18 | Keith Horn | Director | Option exercise | 838 | — | — |
| 2026-04-18 | Odysseas Kostas D | Director | Option exercise | 838 | — | — |
| 2026-04-01 | Fishman Peter L. | SVP, CFO | Option exercise | 125 | — | — |
| 2026-01-31 | Fishman Peter L. | SVP, CFO | Option exercise | 563 | — | — |
| 2026-01-31 | Fishman Peter L. | SVP, CFO | Option exercise | 1.8K | — | — |
1–10 of 16
Page 1 / 2